Switch to
More onapp

Kwality Pharmaceuticals Ltd

KPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹342 cr, stock is ranked 1,520
High RiskStock is 3.12x as volatile as Nifty
333.000.60 (-0.18%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹342 cr, stock is ranked 1,520
High RiskStock is 3.12x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
2.85
PB RatioPB Ratio
1.90
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kwality Pharmaceuticals Limited is an India-based company, which is engaged in the business of manufacturing and trading in pharmaceuticals and allied products. The Company operates through the segment of manufacturing a range of finished pharmaceutical formulations in a dosage form, such as tablets, liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solutions (ORS), among others. It provides pharmaceutical formulations in various categories, such as beta-lactam and non-beta lactam, hormones and cytotoxic (oncology). It manufactures beta-lactam and cephalosporin molecules in various dosage forms, such as tablets, capsules, dry powder for suspension and dry powder for injection. It manufactures the anticancer products in various dosage forms, such as tablets, capsules and injectables. Its products are available in Europe, Africa and Asian countries, among others.

Financial TrendFinancial statements 

2019202020212022166.90142.96263.60459.707.578.3315.16120.00
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 22, 2022

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in Directorate | Download

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in Directorate | Download

Company Update 
Announced OnNov 16, 2022

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Cash Dividend 
Ex. DateJan 5, 2017

Interim • Div/Share: ₹ 0.6

See all events